| Quote
: |
杨紫玉,杨科,朱晓新,刘新民,胡秦,陈颖.黄精保健食品的开发现状及产业发展分析[J].湖南中医药大学学报英文版,2020,40(7):853-859.[Click to copy
] |
|
| |
|
|
| This paper
：Browser 2799times Download 628times |
| 黄精保健食品的开发现状及产业发展分析 |
| 杨紫玉,杨科,朱晓新,刘新民,胡秦,陈颖 |
| (中国中医科学院中药研究所, 北京 100700;浙江工业大学长三角绿色制药协同创新中心, 浙江 杭州 310014;中国医学科学院协和医学院药用植物研究所, 北京 100193;北京工业大学生命科学与生物工程学院, 北京 100124) |
| 摘要: |
| 目的 了解我国以黄精为原料的保健食品的现状，为黄精产品深加工方向提供建议。方法 通过检索国家食品药品监督管理总局数据库查询已经公布的黄精保健食品注册信息，统计1997-2019年间批准的产品数量、申报人地址、主要功能、适宜人群等信息，并结合BibExcel软件对黄精保健食品的主要配伍关系分析，采用Ucinet 6.0软件中NetDraw构建可视化网络。结果 （1）1997-2019年间我国注册黄精保健食品351个，主要分布于北京、广东、浙江等31个省市；（2）黄精保健食品的保健功能主要为抗疲劳（36.2%）、增强免疫力（33.1%），还具有调节血糖、延缓衰老、改善睡眠等功能；（3）黄精保健食品剂型以胶囊（49%）、药酒（19%）、口服液（12%）为主；（4）黄精保健食品的适宜人群主要为易疲劳者（35.7%）与免疫力低下者（41.6%），其次为血糖偏高者、中老年人等；（5）已获批含黄精保健食品最常见配伍为黄精配伍枸杞子。结论 黄精产业发展潜力大，应加强对黄精保健食品的深度开发，拓宽产品的应用方向，制定标准化的加工流程，建立优质产品评价体系，促进我国黄精产业发展。 |
| 关键词: 黄精 保健食品 抗疲劳 血糖 免疫力 |
| DOI：10.3969/j.issn.1674-070X.2020.07.014 |
| Received:February 26, 2020 |
| 基金项目:国家科技重大专项（2017ZX09101002-002-008）；国家自然科学基金项目（81760783）；载人航天工程航天医学实验领域项目资助（HYZHXM05003）。 |
|
| Development Status and Industry Development Analysis of Polygonati Rhizoma Health-Care Food |
| YANG Ziyu,YANG Ke,ZHU Xiaoxin,LIU Xinmin,HU Qin,CHEN Ying |
| (Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China;Yangtze River Delta Green Pharmaceutical Collaborative Innovation Center, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China;Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China;College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China) |
| Abstract: |
| Objective To understand the status quo of health-care foods using Polygonati Rhizoma as raw material in China, and to provide suggestions for the deep processing of Polygonati Rhizoma products. Methods By searching the registered information of Polygonati Rhizoma health-care food which has been published by State Food and Drug Administration Database, the number of products approved between 1997 and 2019, the address of the applicant, the main function and the suitable population were collected. And combining with the Bibexcel analysis software, the main compatibility of Polygonati Rhizoma health-care food was extracted and sorted. The NetDraw in Ucinet 6.0 software was used to construct visual network. Results (1) Totally 351 types of Polygonati Rhizoma health-care food were registered in 1997-2019, distributed in Beijing, Guangzhou, Zhejiang and other 31 provinces and cities; (2) The functions of Polygonati Rhizoma health-care food were mainly anti-fatigue (36.2%), enhancing immunity (33.1%), and also with the functions of regulating blood sugar, delaying aging, improving sleep and so on; (3) The dosage forms of Polygonati Rhizoma health-care food were mainly capsule (49%), medicinal wine (19%), oral liquid (12%); (4) The suitable population of Polygonati Rhizoma health-care food was mainly fatigue-prone (35.7%) and immunocompromised (41.6%), followed by high blood sugar, middle-aged and elderly; (5) The most common compatibility of approved products containing Polygonati Rhizoma was Polygonati Rhizoma with Fructus Lycii. Conclusion There is great potential for the development of Polygonati Rhizoma industry. We should strengthen the in-depth development of Polygonati Rhizoma health-care food, broaden the application direction of products, formulate standardized processing procedures, establish an evaluation system of high-quality product, and promote the development of Polygonati Rhizoma industry in our country. |
| Key words: Polygonati Rhizoma health-care food anti-fatigue blood sugar immunity |
|
二维码（扫一下试试看！） |
|
|
|
|
